AstraZeneca’s Covid-19 Vaccine Proves Its Worth in Phase III
A much anticipated Covid-19 vaccine, developed by the University of Oxford and AstraZeneca, achieved 70%…
A much anticipated Covid-19 vaccine, developed by the University of Oxford and AstraZeneca, achieved 70%…
MiroBio has spun out of the University of Oxford with a Series A round of…
CN Bio Innovations has globally launched an organ-on-a-chip device that allows scientists to test potential…
NightstaRx has raised €39.5M that will go towards three clinical programs testing gene therapies for…
Evotec and the University of Oxford have announced the academic projects that will receive a…
Scenic Biotech is applying a technology to identify first-in-class therapeutic targets that has secured it…
Mission Therapeutics has received a grant to support the development of a novel approach to…
Microbe Stories, in London, is now exhibiting artwork from Anna Dumitriu, a proclaimed bioartist that…
The Museum of the History of Science in Oxford is hosting an exhibition on the…
An HIV vaccine developed at the University of Oxford has kept 5 out of 15 patients…
A new research center funded by Novo Nordisk will foster collaborations between its staff and…